Gavestinel sodium salt salt form · sodium · Parent Gavestinel sodium salt

Gavestinel is a potent, selective, orally active and non-competitive antagonist of NMDA receptor.

For research use only. Not for human or veterinary use.

Target iGluR

Research area Cardiovascular Disease

Purity >98% Stock Inquire

Data Sheet SDS COA

Gavestinel sodium salt structure

CAS No.: 153436-38-5

Download structure (.mol)

Pack sizes & pricing

Size	Price	SKU	Stock
250 mg	USD 470.00	BP-02189A-250mg	In stock	Get quote
500 mg	USD 750.00	BP-02189A-500mg	In stock	Get quote
1 g	USD 1,200.00	BP-02189A-1g	In stock	Get quote
2 g	USD 1,920.00	BP-02189A-2g	In stock	Get quote
3 g	USD 2,300.00	BP-02189A-3g	In stock	Get quote
5 g	USD 3,120.00	BP-02189A-5g	In stock	Get quote

Need another size or custom synthesis? Request a quote.

Description

Gavestinel (GV 150526A) is a potent, selective, orally active and non-competitive antagonist of NMDA receptor. Gavestinel binds to the glycine site of the NMDA receptor, with a pKi of 8.5. Gavestinel can be used for the research of acute ischemic stroke .

Identifiers

SMILES: O=C(NC1=CC=CC=C1)/C=C/C2=C(C(O[Na])=O)NC3=CC(Cl)=CC(Cl)=C23
InChIKey: GRSDSTMFQHAESM-UHDJGPCESA-M

Specifications

MW (average): 397.1870
Formula: C₁₈H₁₁Cl₂N₂NaO₃
CAS No.: 153436-38-5
Physical state: Solid
Color: White to light yellow
Shipping: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage: Powder 4°C, sealed storage, away from moisture; In solvent -20°C, 1 month;

Solubility

soluble in DMSO

Documents

References

[1]. Fabio RD, et, al. Substituted indole-2-carboxylates as in vivo potent antagonists acting as the strychnine-insensitive glycine binding site. J Med Chem. 1997 Mar 14;40(6):841-50.

Same target

Search iGluR

Same research area

Search Cardiovascular Disease